Journal
GASTROENTEROLOGY CLINICS OF NORTH AMERICA
Volume 42, Issue 2, Pages 359-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.gtc.2013.01.011
Keywords
Gastric cancer; Gastric adenocarcinoma; Multidisciplinary approach; Perioperative; Chemoradiation; Adjuvant therapy
Categories
Funding
- Park Family
- Caporella Family
- Bikoff Family
- Cantu Family
- Fairman Family
- Dallas Family
- Oaks Family
- Sultan Family
- Dio Family
- Frazier Family
- Kevin Fund
- Schecter Private Foundation
- Rivercreek Foundation
Ask authors/readers for more resources
Gastric cancer (GC) is a major health burden throughout the world, especially in certain endemic regions. GC is commonly diagnosed at an advanced stage because of the lack of early detection strategies and is usually associated with a dismal outcome. For patients with localized GC (LGC), surgery is the best cure: cure rates are highly associated with the surgical pathology stage. Adjunctive therapies improve the cure rates by about an additional 10%. Therefore, a multimodality approach is highly recommended for all patients with LGC. This article highlights some of the therapeutic advances made against GC and features important ongoing trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available